MIR vs. RVTY, AVTR, BIO.B, NVMI, VNT, ST, CAMT, TXG, TRNS, and CTKB
Should you be buying Mirion Technologies stock or one of its competitors? The main competitors of Mirion Technologies include Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Sensata Technologies (ST), Camtek (CAMT), 10x Genomics (TXG), Transcat (TRNS), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry.
Mirion Technologies vs.
Mirion Technologies (NYSE:MIR) and Revvity (NYSE:RVTY) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, community ranking, dividends, profitability, analyst recommendations, institutional ownership and valuation.
Revvity has higher revenue and earnings than Mirion Technologies. Mirion Technologies is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.
In the previous week, Revvity had 7 more articles in the media than Mirion Technologies. MarketBeat recorded 12 mentions for Revvity and 5 mentions for Mirion Technologies. Revvity's average media sentiment score of 0.94 beat Mirion Technologies' score of 0.00 indicating that Revvity is being referred to more favorably in the news media.
78.5% of Mirion Technologies shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 2.2% of Mirion Technologies shares are owned by company insiders. Comparatively, 0.6% of Revvity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Mirion Technologies presently has a consensus price target of $19.25, suggesting a potential upside of 30.38%. Revvity has a consensus price target of $136.25, suggesting a potential upside of 24.79%. Given Mirion Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe Mirion Technologies is more favorable than Revvity.
Revvity received 13 more outperform votes than Mirion Technologies when rated by MarketBeat users. However, 84.21% of users gave Mirion Technologies an outperform vote while only 61.70% of users gave Revvity an outperform vote.
Revvity has a net margin of 9.81% compared to Mirion Technologies' net margin of -4.21%. Revvity's return on equity of 7.68% beat Mirion Technologies' return on equity.
Mirion Technologies has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500. Comparatively, Revvity has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500.
Summary
Revvity beats Mirion Technologies on 14 of the 19 factors compared between the two stocks.
Get Mirion Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MIR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mirion Technologies Competitors List
Related Companies and Tools
This page (NYSE:MIR) was last updated on 3/4/2025 by MarketBeat.com Staff
Free MIR Stock Alerts